- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | NICE finalises support for CSL's HAE therapy Andembry | ||
| Mi | Sanofi, Orano cue up filings for GEP-NET radioligand therapy | ||
| Mi | J&J on the hook for $966m damages in latest talc lawsuit | ||
| Mi | Boehringer bags FDA okay for new pulmonary fibrosis drug | ||
| Mi | After FDA exit, Peter Marks pops up at Lilly | ||
| Di | MSD advances on a broad front with TL1A drug tulisokibart | ||
| Di | AZ chalks up another positive trial for hypertension drug | ||
| Di | Ignota vacuums up Kronos Bio's drug programmes | ||
| Di | Acting CDC director says MMR jabs should be split | ||
| Di | Regulatory T-cell scientist trio wins Nobel Prize | ||
| Mo | Oculis takes second eye disease therapy into pivotal trials | ||
| Mo | UK's Trogenix raises £70m for cancer immunotherapy platform | ||
| Mo | Roche gets EU nod for kidney disease algorithm | ||
| Mo | Delayed TNBC readout for Datroway delivers survival benefit | ||
| Fr | Rocket aborts FDA filing for Fanconi gene therapy | ||
| Fr | Cidara gets $339m BARDA award for flu prophylactic | ||
| Fr | GLP-1s from Novo, Lilly 'should be first-line in obesity' | ||
| Fr | Jazz Pharma, Roche combo cleared by FDA for lung cancer | ||
| Fr | FDA angers anti-abortion lobby with generic abortion pill OK | ||
| 02.10. | Pharma tariffs yet to emerge as Trump seeks more deals | ||
| 02.10. | Three more pharmas join OpenFold3 AI consortium | ||
| 01.10. | Crystalys emerges with $205m, and other biofinancings | ||
| 01.10. | Indivior stops Opvee promotion in New York after settlement | ||
| 01.10. | Sanofi faces EU antitrust probe into vaccine business | ||
| 01.10. | Umoja's in vivo cell therapy fast-tracked by FDA |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .